Literature DB >> 23589163

Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS).

A L Schafer1, A J Burghardt, D E Sellmeyer, L Palermo, D M Shoback, S Majumdar, D M Black.   

Abstract

SUMMARY: In postmenopausal women receiving combination parathyroid hormone (PTH) (1-84) therapy and ibandronate, we evaluated bone microarchitecture and biomechanics using high-resolution peripheral quantitative computed tomography (HR-pQCT). Cortical and trabecular changes were different at the nonweight-bearing radius vs. the weight-bearing tibia, with more favorable overall changes at the tibia.
INTRODUCTION: PTH therapy and bisphosphonates decrease fracture risk in postmenopausal osteoporosis, but their effects on bone microstructure and strength have not been fully characterized, particularly during combination therapy. PTH increases trabecular bone mineral density (BMD) substantially but may decrease cortical BMD, possibly by stimulating intracortical remodeling. We evaluated bone microarchitecture and biomechanics with HR-pQCT at the radius (a nonweight-bearing site) and tibia (weight bearing) in women receiving combination PTH(1-84) and ibandronate.
METHODS: Postmenopausal women with low bone mass (n = 43) were treated with 6 months of PTH(1-84) (100 μg/day), either as one 6- or two 3-month courses, in combination with ibandronate (150 mg/month) over 2 years. HR-pQCT was performed before and after therapy.
RESULTS: Because changes in HR-pQCT parameters did not differ between treatment arms, groups were pooled into one cohort for analysis. Trabecular BMD increased at both radius and tibia (p < 0.01 for each). Cortical thickness and BMD decreased at the radius (p < 0.01), consistent with changes in dual-energy X-ray absorptiometry, while these parameters did not change at the tibia (p ≤ 0.02 for difference between radius and tibia). In contrast, cortical porosity increased at the tibia (p < 0.01) but not radius. Stiffness and failure load decreased at the radius (p < 0.0001) but did not change at the tibia.
CONCLUSIONS: Cortical and trabecular changes in response to the PTH/ibandronate treatment combinations utilized in this study were different at the nonweight-bearing radius vs. the weight-bearing tibia, with more favorable overall changes at the tibia. Our findings support the possibility that weight bearing may optimize the effects of osteoporosis therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589163     DOI: 10.1007/s00198-013-2349-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  43 in total

Review 1.  The anabolic effects of parathyroid hormone.

Authors:  M R Rubin; F Cosman; R Lindsay; J P Bilezikian
Journal:  Osteoporos Int       Date:  2002       Impact factor: 4.507

2.  Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial.

Authors:  R D Chapurlat; M Laroche; T Thomas; S Rouanet; P D Delmas; M-C de Vernejoul
Journal:  Osteoporos Int       Date:  2012-03-09       Impact factor: 4.507

3.  In vivo determination of bone structure in postmenopausal women: a comparison of HR-pQCT and high-field MR imaging.

Authors:  Galateia J Kazakia; Benedict Hyun; Andrew J Burghardt; Roland Krug; David C Newitt; Anne E de Papp; Thomas M Link; Sharmila Majumdar
Journal:  J Bone Miner Res       Date:  2008-04       Impact factor: 6.741

4.  Direct mechanics assessment of elastic symmetries and properties of trabecular bone architecture.

Authors:  B Van Rietbergen; A Odgaard; J Kabel; R Huiskes
Journal:  J Biomech       Date:  1996-12       Impact factor: 2.712

5.  Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.

Authors:  Ego Seeman; Pierre D Delmas; David A Hanley; Deborah Sellmeyer; Angela M Cheung; Elizabeth Shane; Ann Kearns; Thierry Thomas; Steven K Boyd; Stephanie Boutroy; Cesar Bogado; Sharmila Majumdar; Michelle Fan; Cesar Libanati; Jose Zanchetta
Journal:  J Bone Miner Res       Date:  2010-08       Impact factor: 6.741

6.  Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.

Authors:  Stinus Hansen; Ellen M Hauge; Jens-Erik Beck Jensen; Kim Brixen
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

7.  Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment.

Authors:  Chi Hyun Kim; Erica Takai; Hua Zhou; Dietrich von Stechow; Ralph Müller; David W Dempster; X Edward Guo
Journal:  J Bone Miner Res       Date:  2003-12       Impact factor: 6.741

8.  Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial.

Authors:  Anne L Schafer; Deborah E Sellmeyer; Lisa Palermo; Jean Hietpas; Richard Eastell; Dolores M Shoback; Dennis M Black
Journal:  J Clin Endocrinol Metab       Date:  2012-07-12       Impact factor: 5.958

9.  Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials.

Authors:  Longxiang Shen; Xuetao Xie; Yan Su; Congfeng Luo; Changqing Zhang; Bingfang Zeng
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

10.  Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia.

Authors:  Andrew J Burghardt; Galateia J Kazakia; Sweta Ramachandran; Thomas M Link; Sharmila Majumdar
Journal:  J Bone Miner Res       Date:  2010-05       Impact factor: 6.741

View more
  15 in total

Review 1.  Clinical Evaluation of Bone Strength and Fracture Risk.

Authors:  Chantal M J de Bakker; Wei-Ju Tseng; Yihan Li; Hongbo Zhao; X Sherry Liu
Journal:  Curr Osteoporos Rep       Date:  2017-02       Impact factor: 5.096

2.  Simplified boundary conditions alter cortical-trabecular load sharing at the distal radius; A multiscale finite element analysis.

Authors:  Joshua E Johnson; Karen L Troy
Journal:  J Biomech       Date:  2017-11-04       Impact factor: 2.712

3.  A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part II: 1-Yr Change, Long-Term Precision, and Least Significant Change.

Authors:  Andy K O Wong; Karen A Beattie; Kevin K H Min; Zamir Merali; Colin E Webber; Christopher L Gordon; Alexandra Papaioannou; Angela M W Cheung; Jonathan D Adachi
Journal:  J Clin Densitom       Date:  2014-08-13       Impact factor: 2.617

4.  Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography.

Authors:  D E Whittier; S K Boyd; A J Burghardt; J Paccou; A Ghasem-Zadeh; R Chapurlat; K Engelke; M L Bouxsein
Journal:  Osteoporos Int       Date:  2020-05-26       Impact factor: 4.507

5.  Peripheral quantitative computed tomography (pQCT)-based finite element analysis provides enhanced diagnostic performance in identifying non-vertebral fracture patients compared with dual-energy X-ray absorptiometry.

Authors:  H Jiang; D L Robinson; C J Yates; P V S Lee; J D Wark
Journal:  Osteoporos Int       Date:  2019-11-13       Impact factor: 4.507

6.  μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy.

Authors:  Chantal M J de Bakker; Allison R Altman; Wei-Ju Tseng; Mary Beth Tribble; Connie Li; Abhishek Chandra; Ling Qin; X Sherry Liu
Journal:  Bone       Date:  2014-12-30       Impact factor: 4.398

7.  Intermittent Parathyroid Hormone After Prolonged Alendronate Treatment Induces Substantial New Bone Formation and Increases Bone Tissue Heterogeneity in Ovariectomized Rats.

Authors:  Allison R Altman-Singles; Yonghoon Jeong; Wei-Ju Tseng; Chantal Mj de Bakker; Hongbo Zhao; Carina Lott; Juhanna Robberts; Ling Qin; Lin Han; Do-Gyoon Kim; X Sherry Liu
Journal:  J Bone Miner Res       Date:  2017-06-13       Impact factor: 6.741

8.  Validation of a new multiscale finite element analysis approach at the distal radius.

Authors:  Joshua E Johnson; Karen L Troy
Journal:  Med Eng Phys       Date:  2017-03-31       Impact factor: 2.242

9.  A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment.

Authors:  Allison R Altman; Wei-Ju Tseng; Chantal M J de Bakker; Beom Kang Huh; Abhishek Chandra; Ling Qin; X Sherry Liu
Journal:  Bone       Date:  2014-01-24       Impact factor: 4.398

Review 10.  Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses.

Authors:  Eric Lespessailles; Ridha Hambli; Serge Ferrari
Journal:  Bonekey Rep       Date:  2016-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.